Pfizer, Eli Lilly, Bristol-Myer and J&J initiated with buy ratings by Goldman Sachs
May 28, 2019 at 15:02 PM EDT
Goldman Sachs started coverage of some big drug stocks on Tuesday in a bullish note.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
